Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥167,727 | ¥156,819 | ¥121,790 | ¥117,824 |
| - Cash | ¥25,169 | ¥22,894 | ¥25,893 | ¥30,013 |
| + Debt | ¥1,280 | ¥1,340 | ¥1,490 | ¥1,640 |
| Enterprise Value | ¥143,838 | ¥135,265 | ¥97,387 | ¥89,451 |
| Revenue | ¥88,330 | ¥75,579 | ¥67,493 | ¥65,381 |
| % Growth | 16.9% | 12% | 3.2% | – |
| Gross Profit | ¥44,065 | ¥37,341 | ¥32,375 | ¥31,238 |
| % Margin | 49.9% | 49.4% | 48% | 47.8% |
| EBITDA | ¥20,250 | ¥18,720 | ¥17,808 | ¥20,261 |
| % Margin | 22.9% | 24.8% | 26.4% | 31% |
| Net Income | ¥11,961 | ¥11,160 | ¥10,528 | ¥12,921 |
| % Margin | 13.5% | 14.8% | 15.6% | 19.8% |
| EPS Diluted | 274.2 | 246.58 | 228.3 | 280.19 |
| % Growth | 11.2% | 8% | -18.5% | – |
| Operating Cash Flow | ¥6,521 | -¥1,677 | -¥6,679 | ¥1,533 |
| Capital Expenditures | -¥4,507 | -¥1,833 | -¥2,547 | -¥1,919 |
| Free Cash Flow | ¥2,014 | -¥3,510 | -¥9,226 | -¥386 |